MOD-5014

BIOLOGICAL2 trials

Sponsors

OPKO Health, Inc.

Conditions

Hemophilia AHemophilia A or B With InhibitorsHemophilia B

Phase 1

A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B

CompletedNCT02418793

OPKO Health, Inc.Hemophilia A, Hemophilia B

Start: 2015-05-31End: 2018-09-30Updated: 2021-05-20

A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male

CompletedNCT02919800

OPKO Health, Inc.Hemophilia A or B With Inhibitors

Start: 2017-01-22End: 2018-02-21Updated: 2019-09-30